Rigel Pharmaceuticals ... rating system plays an important role, as it effectively harnesses the power of earnings estimate revisions. The Zacks Rank stock-rating system, which uses four factors ...

Jan. 13, 2025 /PRNewswire/ -- Rigel Pharmaceuticals ... patient fails to achieve remission even after intensive treatment.4 Quality of life declines for patients with each successive line ...

While Rigel is still determining final results for the fourth quarter of 2024, the company expects to report fourth quarter total revenue of $57.6M, compared to $35.8M for the same period of 2023.

(RTTNews) - Rigel Pharmaceuticals, Inc. (RIGL) said it expects to report fourth quarter total revenue of $57.6 million, compared to $35.8 million for the same period of 2023. Rigel expects to ...

Specifically, Rigel granted 46,131 stock options to eight non-executive employees vesting over four years with a one-year cliff. About Rigel Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) is a ...

SOUTH SAN FRANCISCO, Calif., Jan. 13, 2025 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer ...